Literature DB >> 6123971

Hazards of medical glaucoma therapy in the cataract patient.

E M Van Buskirk.   

Abstract

Particular glaucoma drug hazards for cataract patients include miosis, exacerbation of lens opacity, pupillary block, and the development of systemic adrenergic or cholinergic adverse drug effects or interaction. Each available antiglaucoma drug needs to be selected in individual cases with the knowledge of side effects that are likely to develop. For the glaucoma-cataract patient, a glaucoma regimen need be designed to minimize visual impairment, to minimize exacerbation of cataract, and to prevent introduction of new ocular disorders. At the time of cataract surgery, the regimen should be reassessed to maximize a smooth operative course and minimize systemic operative and anesthetic complications.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6123971     DOI: 10.1016/s0161-6420(82)34811-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  2 in total

1.  Is glaucoma associated with an increased risk of cataract?

Authors:  E V Kuppens; J A van Best; C C Sterk
Journal:  Br J Ophthalmol       Date:  1995-07       Impact factor: 4.638

Review 2.  Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension.

Authors:  Angelo P Tanna; Mark Johnson
Journal:  Ophthalmology       Date:  2018-07-12       Impact factor: 12.079

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.